Colchicine and the combination of rivaroxaban and aspirin in patients hospitalised with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial John W Eikelboom , Sanjit S Jolly , Emilie P Belley-Cote , Richard P Whitlock , Sumathy Rangarajan , Lizhen Xu , Laura Heenan , Shrikant I Bangdiwala , Maria Luz Diaz , Rafael Diaz , Afzalhussein Yusufali , Sanjib Kumar Sharma , Wadea M Tarhuni , Mohamed Hassany , Alvaro Avezum , William Harper , Sean Wasserman , Aysha Almas , Oxana Drapkina , Camilo Felix , Renato D Lopes , Otavio Berwanger , Patricio Lopez-Jaramillo , Sonia S Anand , Jackie Bosch , Shurjeel Choudhri , Michael E Farkouh , Mark Loeb , Salim Yusuf The Lancet Respiratory Medicine(2022)
摘要
For the Portuguese, Russian and Spanish translations of the abstract see Supplementary Materials section.
更多 查看译文
AI 理解论文
溯源树
样例